Latest ResoTher Pharma News & Updates

See the latest news and media coverage for ResoTher Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
ResoTher Pharma

Clinical-stage biotech developing resolution therapies for cardiovascular inflammation

resotherpharma.com
Headquarters
Holte, Denmark
Founded year
2016
Company type
Private company
Number of employees
2–20

Latest news about ResoTher Pharma

Company announcements

  • ResoTher Pharma

    CFO chooses ResoTher Pharma

    CFO of two companies selects ResoTher due to exciting funding, biotech passion, and Phase 2 trial launch. Article in Danish.

  • ResoTher Pharma

    ResoTher Pharma initiates dosing in Phase 2a trial

    The trial assesses RTP-026 safety and efficacy in STEMI patients at sites in Denmark and UK. It aims to enroll 96 patients.

  • ResoTher Pharma

    ResoTher Pharma receives €2.5 million EIC grant

    The grant supports Phase 2a clinical study of RTP-026 for myocardial infarction. One of 47 projects selected from 648 proposals.

  • ResoTher Pharma

    ResoTher Pharma appoints Anders Kronborg as CEO

    The appointment takes effect February 1, 2023. He succeeds Lone Veng, who led since 2017 and advanced RTP-026 into clinical development.

Unlock all announcements with a

Media coverage

  • BioWorld

    Resother Pharma synthesizes new FPR2 agonists

    Resother Pharma ApS has divulged new N-formyl peptide receptor 2 (FPR2; FPRL1; LXA4) agonists potentially useful for the treatment of chronic inflammation.

  • Økonomisk Ugebrev

    ResoTher Pharma works with peptide-based molecules

    ResoTher Pharma is a Danish biotech company that develops new therapeutic agents based on a unique approach to inflammatory treatment. ResoTher works with peptide-based molecules that...

Track future articles with a

Never miss news about ResoTher Pharma

Track ResoTher Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.